29 Sept 2023
A study presented at the European Association for the Study of Diabetes Annual Meeting has found that the weight loss drug Tirzepatide is more effective than Semaglutide in improving HbA1c and reducing weight in patients with type 2 diabetes.
Study links premature ovarian insufficiency (POI) to risk of mortality
17 May 2024
Cardiovascular disease mortality associated with low testosterone in men
17 May 2024
People with obesity using semaglutide see cardiovascular improvements
17 May 2024
Men with obesity lose more weight with cash incentives, research says
17 May 2024
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024